| scholarly article | Q13442814 |
| P50 | author | Salmir Nasic | Q57319805 |
| P2093 | author name string | Asplund K | |
| Rodu B | |||
| Eliasson M | |||
| P2860 | cites work | No increase in the prevalence of known diabetes between 1986 and 1999 in subjects 25-64 years of age in northern Sweden | Q44163436 |
| The relation of smoking to waist-to-hip ratio and diabetes mellitus among elderly women. | Q45991329 | ||
| Insulin resistance and cigarette smoking | Q46042642 | ||
| Evolving patterns of tobacco use in northern Sweden | Q47901529 | ||
| Cigarette smoking, oral moist snuff use and glucose intolerance. | Q51554360 | ||
| Impact of cigarette smoking on the incidence of Type 2 diabetes mellitus in middle-aged Japanese men: the Osaka Health Survey. | Q51559545 | ||
| A prospective study of cigarette smoking and the incidence of diabetes mellitus among us male physicians | Q57616858 | ||
| Altered skeletal muscle glucose transport and blood lipid levels in habitual cigarette smokers | Q58449890 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Sweden | Q34 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 101-110 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Journal of Internal Medicine | Q6295387 |
| P1476 | title | Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study | |
| P478 | volume | 256 |
| Q37606703 | An epidemiologic review of smokeless tobacco health effects and harm reduction potential |
| Q39002723 | Association between iq'mik smokeless tobacco use and cardiometabolic risk profile among Yup'ik Alaska Native people |
| Q61458244 | Association between metabolic effects and tobacco use in 60-year-old Swedish men |
| Q33973459 | Association of tobacco products use and diabetes mellitus-results of a national survey among adults in saudi arabia |
| Q36166078 | Burden and Socio-Behavioral Correlates of Uncontrolled Abnormal Glucose Metabolism in an Urban Population of India |
| Q40213880 | Chronic disease and lifestyle transitions: results from the Longitudinal Aging Study Amsterdam. |
| Q56836070 | Contribution of Swedish moist snuff to the metabolic syndrome: A wolf in sheep's clothing? |
| Q36378206 | Effects of smokeless tobacco "Maras powder" use on nitric oxide and cardiovascular risk parameters |
| Q35085218 | Impact of differing definitions of dual tobacco use: implications for studying dual use and a call for operational definitions |
| Q36902719 | Metabolic and cardiovascular effects of smokeless tobacco |
| Q37435551 | Smokeless Tobacco and Stroke - A Clinico-epidemiological Follow-up Study in A Tertiary Care Hospital |
| Q38977509 | Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from five pooled cohorts |
| Q37387040 | Smokeless tobacco and cardiovascular disease in low and middle income countries |
| Q34554017 | Smoking and the risk of type 2 diabetes |
| Q39978608 | Snuff use associated with abdominal obesity in former smokers |
| Q24597926 | Snus use and other correlates of smoking cessation in the Swedish Twin Registry |
| Q33721437 | Socio-demographic, lifestyle and health characteristics among snus users and dual tobacco users in Stockholm County, Sweden |
| Q37821539 | Summary of the epidemiological evidence relating snus to health. |
| Q33454038 | Swedish snuff and incidence of cardiovascular disease. A population-based cohort study |
| Q47988381 | The -374T/A variant of the rage gene promoter is associated with clinical restenosis after coronary stent placement |
| Q36795880 | The Collaborative Study of Obesity and Diabetes in Adults (CODA) project: meta-analysis design and description of participating studies. |
| Q34038743 | The STAGE cohort: a prospective study of tobacco use among Swedish twins |
| Q47736455 | The relationship of snus use to diabetes and allied conditions |
| Q21093267 | Tobacco harm reduction: an alternative cessation strategy for inveterate smokers |
| Q39648112 | Use of Swedish smokeless tobacco (snus) and the risk of Type 2 diabetes and latent autoimmune diabetes of adulthood (LADA). |
| Q33909359 | Weight gain and incident obesity among male snus users |
Search more.